CClinicalTrials.gg
RecruitingNCT07084701NSCLDUpdated Jan 13, 2026

Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study

An interventional study of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) and sham-intervention treatment in Sleep Deprivation, sponsored by Tao Liu. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by Tao Liu · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.

Read the detailed description

Sleep deprivation (SD) is widespread in modern society, particularly among medical students, residents, and individuals in high-stress occupations. Numerous studies have demonstrated that acute sleep deprivation significantly impairs cognitive processes such as attention, working memory, and executive function. Even short-term cognitive impairment can have serious consequences, including impaired judgment, slowed reaction times, and increased error rates.

Currently, interventions targeting cognitive decline following sleep deprivation are limited. Common strategies primarily include medications (such as caffeine and modafinil) and restorative sleep. However, these methods have limitations in both clinical and real-life settings: on one hand, medications may lead to tolerance and side effects, and on the other hand, restorative sleep often cannot reverse cognitive impairment in the short term. Therefore, developing a safe, convenient, and rapidly effective non-pharmacological intervention is of great significance.

In recent years, the glymphatic system has garnered increasing attention. This system is believed to play a key role in clearing metabolic waste from the brain, regulating sleep structure, and maintaining neurocognitive function. Superficial craniocervical lymphatic drainage (SCLD) has been proposed as a potential mechanism to improve cognitive function by enhancing the flow of cerebrospinal fluid (CSF) and lymph, reducing neuroinflammation, and minimizing the accumulation of metabolic waste.

In June 2025, a study published in Nature provided the first in vivo evidence supporting this hypothesis. Researchers applied non-invasive mechanical stimulation to the superficial lymphatic system on the skin surface of the mouse neck, resulting in a doubling of CSF drainage efficiency to cervical lymph nodes and correction of impaired brain-lymphatic efflux function in aged mice. These findings provide direct mechanistic support for the potential application of non-invasive SCLD intervention in humans.

Therefore, this study aims to establish an acute sleep deprivation model in healthy adults and explore the immediate effects of NSCLD intervention on cognitive function, with the goal of providing preliminary clinical evidence for non-pharmacological intervention strategies related to the brain-lymphatic pathway.

02

Conditions studied

  • Sleep Deprivation

Browse trials for

Keywords

  • Sleep Deprivation
  • Non-Invasive Superficial Craniocervical Lymphatic Drainage
  • Memory
  • Cognitive Function
  • NSCLD
03

In context

Sleep Deprivation

300 studies on the registry are indexed under Sleep Deprivation; 60 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 248 interventional studies indexed under Sleep Deprivation.

Browse Sleep Deprivation studies →

Lead sponsor

Tao Liu is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • College student ≥18 years, all of whom have passed a standardized entrance examination;
  • No failed exams during the course of study;
  • Sleep deprivation;
  • In good health, with no mental or psychological disorders;
  • No recent use of medications that may affect memory and cognition;
  • Voluntary participation and able to undergo cognitive function and memory testing;
  • Informed consent provided

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding women.
  • Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results.
  • History of craniocervical trauma or surgery.
  • Current use of sedative or anxiolytic medications that could influence sleep or cognitive function.
  • Participants who are unable to follow the procedures or complete the assessments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    NSCLD group

    NSCLD for 30 minutes, repeated after a 10-minute interval

    Device: Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)

  • Sham comparator
    Control group

    Device: sham-intervention treatment

Interventions

  • DeviceNon-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)

    Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

  • Devicesham-intervention treatment

    Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

06

What researchers measure

Primary outcomes

  1. Digit Span Test

    Evaluate memory function. 1 point for each correct string of numbers. Total score: forward score + backward score. Higher scores mean a better outcome.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  2. Montreal Cognitive Assessment (MoCA)

    The maximum score is 30 points. ≥26 points is normal. Higher scores mean a better outcome.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

Secondary outcomes

  1. Changes in anxiety, stress, irritability, etc. before and after instant massage

    use Multidimensional VAS Battery. 0 points are "not at all", and 100 points are "extremely strong" (points 0- 100)

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  2. Brain metabolic markers and other metabolic indicators

    Collect blood for analysis of Aβ42/40, T-Tau, p-tau217, Plasma cortisol, Salivary α-Amylase and β-Endorphin.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  3. EEG power in alpha, beta, delta and theta band

    Measure the power of different frequency bands of EEG and compare the changes.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  4. Heart rate variability (HRV)

    Analyze the different indicators of HRV, including RMSSD, LF, HF, LF/HF ratio, SDNN, etc.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  5. modified TOEFL iBT

    Developed by English language professionals based on TOEFL difficulty and standards, with self-compiled test papers. Full marks: 100 points. To evaluate working memory, learning memory, attention allocation, information processing speed, executive functions (such as planning and monitoring), and the retrieval and integration of long-term memory, among other aspects.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  6. Computerized Cognitive Assessment

    Use N-back task and Psychomotor vigilance task (PVT) ,measure metrics such as reaction time and accuracy rate.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

  7. Functional magnetic resonance imaging (fMRI)

    Using functional magnetic resonance imaging to evaluate brain functional activity.

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

07

Study locations

1 of 1 sites recruiting
  • Tianjin Medical University General Hospital
    Tianjin, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07084701
Lead sponsor
Tao Liu
Collaborators
Tianjin Medical University General Hospital, Xuanwu Hospital, Beijing
Responsible party
Tao Liu (MD, The George Institute) — Sponsor-investigator
First posted
Jul 24, 2025
Start date
Sep 15, 2025
Primary completion
Jun 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 13, 2026

Study contacts

Tao Liu, MD
Contact
TLiu1@georgeinstitute.org.au
86-18302204804
Yuezheng Dou
Contact
douyz@tmu.edu.cn

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion